Mechanistic aspects of HIV-1 reverse transcription initiation.
about
Molecular docking of (5E)-3-(2-aminoethyl)-5-(2- thienylmethylene)-1, 3-thiazolidine-2, 4-dione on HIV-1 reverse transcriptase: novel drug acting on enzyme.Few mutations in the 5' leader region mediate fitness recovery of debilitated human immunodeficiency type 1 viruses.Mutations that abrogate human immunodeficiency virus type 1 reverse transcriptase dimerization affect maturation of the reverse transcriptase heterodimer.Conformational changes in HIV-1 reverse transcriptase induced by nonnucleoside reverse transcriptase inhibitor binding.Initiation complex dynamics direct the transitions between distinct phases of early HIV reverse transcription.HMGB1 Is Involved in IFN-α Production and TRAIL Expression by HIV-1-Exposed Plasmacytoid Dendritic Cells: Impact of the Crosstalk with NK CellsFunctional relevance of nonsynonymous mutations in the HIV-1 tat gene within an epidemiologically-linked transmission cohort.Human immunodeficiency virus type 1 protease regulation of tat activity is essential for efficient reverse transcription and replication.Regulation of inflammatory pathways in cancer and infectious disease of the cervixC-C chemokine receptor type five (CCR5): An emerging target for the control of HIV infection.Type I Interferon at the Interface of Antiviral Immunity and Immune Regulation: The Curious Case of HIV-1.Probing the importance of tRNA anticodon: human immunodeficiency virus type 1 (HIV-1) RNA genome complementarity with an HIV-1 that selects tRNA(Glu) for replication.Human immunodeficiency virus type-1 reverse transcriptase exists as post-translationally modified forms in virions and cellsThe availability of the primer activation signal (PAS) affects the efficiency of HIV-1 reverse transcription initiation.HIV-1 Subtypes and 5'LTR-Leader Sequence Variants Correlate with Seroconversion Status in Pumwani Sex Worker Cohort.
P2860
Q30422172-B740463C-E01D-443A-974F-6AEF3E00FA75Q33755126-17BE0295-BC64-4F07-A33E-0A0253FB051AQ33911895-2E7F81DD-D853-4F7E-A0B5-38AD1B986E17Q34163065-E29F6853-6A9D-4D5C-8DB6-392D4E5581EBQ34684128-40132054-58DB-40DC-84E0-C0A752374EA8Q35922101-E398D5B8-9D16-402E-82BA-2A6357668589Q36326743-A8BEBBCB-A177-4BB8-B04F-04C02149B359Q36464170-E9513D0A-DC80-4858-8581-2D2D9A197348Q37288090-6537D808-3DA7-4C45-9147-5A0740969F3AQ37463869-6F0F071D-BF94-44F1-9C57-E527BE83540FQ38181142-F1A2DFB3-EC06-4829-B384-8EA42D7489DDQ39796706-7EA4AF87-401C-4D79-AA96-26B155083C4FQ39904100-F72D0E18-5E4F-468E-92C3-CAE549E6B700Q42764292-A7BF8B2B-0A7B-4420-A927-1932F8E060F7Q47558833-9EFBE52A-B946-406F-BBFC-F46A0DD0D15C
P2860
Mechanistic aspects of HIV-1 reverse transcription initiation.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Mechanistic aspects of HIV-1 reverse transcription initiation.
@ast
Mechanistic aspects of HIV-1 reverse transcription initiation.
@en
Mechanistic aspects of HIV-1 reverse transcription initiation.
@nl
type
label
Mechanistic aspects of HIV-1 reverse transcription initiation.
@ast
Mechanistic aspects of HIV-1 reverse transcription initiation.
@en
Mechanistic aspects of HIV-1 reverse transcription initiation.
@nl
prefLabel
Mechanistic aspects of HIV-1 reverse transcription initiation.
@ast
Mechanistic aspects of HIV-1 reverse transcription initiation.
@en
Mechanistic aspects of HIV-1 reverse transcription initiation.
@nl
P2860
P356
P1476
Mechanistic aspects of HIV-1 reverse transcription initiation.
@en
P2093
Bill Hooker
David Harrich
P2860
P356
10.1002/RMV.339
P577
2002-01-01T00:00:00Z